Literature DB >> 24910096

Necessary and sufficient role for a mitosis skip in senescence induction.

Yoshikazu Johmura1, Midori Shimada1, Toshinori Misaki1, Aya Naiki-Ito2, Hiroyuki Miyoshi3, Noboru Motoyama4, Naoko Ohtani5, Eiji Hara5, Motoki Nakamura6, Akimichi Morita6, Satoru Takahashi2, Makoto Nakanishi7.   

Abstract

Senescence is a state of permanent growth arrest and is a pivotal part of the antitumorigenic barrier in vivo. Although the tumor suppressor activities of p53 and pRb family proteins are essential for the induction of senescence, molecular mechanisms by which these proteins induce senescence are still not clear. Using time-lapse live-cell imaging, we demonstrate here that normal human diploid fibroblasts (HDFs) exposed to various senescence-inducing stimuli undergo a mitosis skip before entry into permanent cell-cycle arrest. This mitosis skip is mediated by both p53-dependent premature activation of APC/C(Cdh1) and pRb family protein-dependent transcriptional suppression of mitotic regulators. Importantly, mitotic skipping is necessary and sufficient for senescence induction. p16 is only required for maintenance of senescence. Analysis of human nevi also suggested the role of mitosis skip in in vivo senescence. Our findings provide decisive evidence for the molecular basis underlying the induction and maintenance of cellular senescence.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24910096     DOI: 10.1016/j.molcel.2014.05.003

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  70 in total

1.  Binucleated HeLa cells are formed by cytokinesis failure in starvation and keep the potential of proliferation.

Authors:  Kazunori Nishimura; Sumiko Watanabe; Ryo Hayashida; Setsuo Sugishima; Tsuyoshi Iwasaka; Tsunehisa Kaku
Journal:  Cytotechnology       Date:  2015-04-18       Impact factor: 2.058

2.  Enter the nucleus to exit the cycle.

Authors:  Lenno Krenning; René H Medema
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 3.  Senescence and apoptosis: dueling or complementary cell fates?

Authors:  Bennett G Childs; Darren J Baker; James L Kirkland; Judith Campisi; Jan M van Deursen
Journal:  EMBO Rep       Date:  2014-10-13       Impact factor: 8.807

Review 4.  Forging a signature of in vivo senescence.

Authors:  Norman E Sharpless; Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2015-07       Impact factor: 60.716

Review 5.  Senescence from G2 arrest, revisited.

Authors:  Véronique Gire; Vjekoslav Dulic
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Accurate delineation of cell cycle phase transitions in living cells with PIP-FUCCI.

Authors:  Gavin D Grant; Katarzyna M Kedziora; Juanita C Limas; Jeanette Gowen Cook; Jeremy E Purvis
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

Review 7.  Ageing and the pathogenesis of osteoarthritis.

Authors:  Richard F Loeser; John A Collins; Brian O Diekman
Journal:  Nat Rev Rheumatol       Date:  2016-05-19       Impact factor: 20.543

8.  Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer.

Authors:  Yoshikazu Johmura; Ichiro Maeda; Narumi Suzuki; Wenwen Wu; Atsushi Goda; Mariko Morita; Kiyoshi Yamaguchi; Mizuki Yamamoto; Satoi Nagasawa; Yasuyuki Kojima; Koichiro Tsugawa; Natsuko Inoue; Yasuo Miyoshi; Tomo Osako; Futoshi Akiyama; Reo Maruyama; Jun-Ichiro Inoue; Yoichi Furukawa; Tomohiko Ohta; Makoto Nakanishi
Journal:  J Clin Invest       Date:  2018-11-12       Impact factor: 14.808

Review 9.  Senescent cells: an emerging target for diseases of ageing.

Authors:  Bennett G Childs; Martina Gluscevic; Darren J Baker; Remi-Martin Laberge; Dan Marquess; Jamie Dananberg; Jan M van Deursen
Journal:  Nat Rev Drug Discov       Date:  2017-07-21       Impact factor: 84.694

10.  Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.

Authors:  J Bargiela-Iparraguirre; L Prado-Marchal; N Pajuelo-Lozano; B Jiménez; R Perona; I Sánchez-Pérez
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.